ZA9108168B - Prolonged release preparation and polymers thereof. - Google Patents

Prolonged release preparation and polymers thereof.

Info

Publication number
ZA9108168B
ZA9108168B ZA9108168A ZA9108168A ZA9108168B ZA 9108168 B ZA9108168 B ZA 9108168B ZA 9108168 A ZA9108168 A ZA 9108168A ZA 9108168 A ZA9108168 A ZA 9108168A ZA 9108168 B ZA9108168 B ZA 9108168B
Authority
ZA
South Africa
Prior art keywords
polymers
release preparation
prolonged release
prolonged
preparation
Prior art date
Application number
ZA9108168A
Inventor
Minoru Yamada
Seiko Ishiguro
Yasuaki Ogawa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP27803790 priority Critical
Priority to JP21704591 priority
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ZA9108168B publication Critical patent/ZA9108168B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04Polyesters derived from hydroxycarboxylic acids, e.g. lactones
ZA9108168A 1990-10-16 1991-10-14 Prolonged release preparation and polymers thereof. ZA9108168B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP27803790 1990-10-16
JP21704591 1991-08-28

Publications (1)

Publication Number Publication Date
ZA9108168B true ZA9108168B (en) 1993-04-14

Family

ID=26521778

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9108168A ZA9108168B (en) 1990-10-16 1991-10-14 Prolonged release preparation and polymers thereof.

Country Status (21)

Country Link
US (1) US5304377A (en)
EP (1) EP0481732B1 (en)
JP (1) JP3196035B2 (en)
CN (2) CN1043189C (en)
AT (1) AT119035T (en)
AU (1) AU644019B2 (en)
CA (1) CA2053468C (en)
DE (1) DE69107773T2 (en)
DK (1) DK0481732T3 (en)
EE (1) EE02958B1 (en)
ES (1) ES2069221T3 (en)
FI (1) FI101454B1 (en)
IE (1) IE66705B1 (en)
LT (1) LT3277B (en)
LV (1) LV10055B (en)
MX (1) MX9101595A (en)
NO (1) NO302481B1 (en)
NZ (1) NZ240214A (en)
PT (1) PT99236B (en)
RU (1) RU2103005C1 (en)
ZA (1) ZA9108168B (en)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
US6005067A (en) * 1992-01-24 1999-12-21 Cargill Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5142023A (en) * 1992-01-24 1992-08-25 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5247058A (en) * 1992-01-24 1993-09-21 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5258488A (en) * 1992-01-24 1993-11-02 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US6326458B1 (en) 1992-01-24 2001-12-04 Cargill, Inc. Continuous process for the manufacture of lactide and lactide polymers
US5247059A (en) * 1992-01-24 1993-09-21 Cargill, Incorporated Continuous process for the manufacture of a purified lactide from esters of lactic acid
DE69322155T2 (en) * 1992-10-02 1999-08-19 Cargill Inc Paper with a coating of melt-stable polymer and the process for preparing
NZ256967A (en) 1992-10-02 1997-04-24 Cargill Inc Fabric formed from a melt-stable lactide polymer composition and uses thereof
US5338822A (en) * 1992-10-02 1994-08-16 Cargill, Incorporated Melt-stable lactide polymer composition and process for manufacture thereof
US6005068A (en) 1992-10-02 1999-12-21 Cargill Incorporated Melt-stable amorphous lactide polymer film and process for manufacture thereof
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
LT3265B (en) 1992-12-07 1995-05-25 Takeda Chemical Industries Ltd Supstained-release preparation and method for its preparing
DK1159974T3 (en) 1993-07-19 2007-11-26 Angiotech Pharm Inc Anti-angiogenic compositions containing taxol and a non-biodegradable carrier, and their use
US5716981A (en) * 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
US5424289A (en) * 1993-07-30 1995-06-13 Alza Corporation Solid formulations of therapeutic proteins for gastrointestinal delivery
AT178789T (en) * 1994-02-21 1999-04-15 Takeda Chemical Industries Ltd Polyester matrix for a pharmaceutical composition with delayed release
FR2718642B1 (en) * 1994-04-15 1996-07-12 Pf Medicament biodegradable microspheres in controlled release and their method of preparation.
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
JP2987064B2 (en) * 1994-09-12 1999-12-06 グンゼ株式会社 Artificial dura mater
EP0765660A3 (en) * 1995-09-28 1998-09-23 Takeda Chemical Industries, Ltd. Microcapsules comprising 2-piperazinone-1-acetic acid compounds
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
DE69615763D1 (en) * 1995-07-13 2001-11-15 Mitsubishi Gas Chemical Co Polymer blends of aliphatic polyesters based on polylactides, processes for their preparation and methods of forming these mixtures
US5637085A (en) * 1995-11-20 1997-06-10 Cardinale; Robert M. Method of cancer tumor treatment by slow release delivery of 1,2,4-benzotriazine oxides to tumor site
DE19545257A1 (en) 1995-11-24 1997-06-19 Schering Ag A process for the production of morphologically uniform microcapsules and produced by this process microcapsules
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
US7235524B2 (en) * 1997-01-31 2007-06-26 Applied Research System Ars Holding N.V. Medicaments for initiating ovulation
FR2744367B1 (en) * 1996-02-02 1999-07-09 Emperaire Jean Claude Drugs for ovulation triggering
WO1997035563A2 (en) * 1996-03-28 1997-10-02 Takeda Chemical Industries, Ltd. Sustained-release preparation and its production
DE69734060T2 (en) * 1996-05-24 2006-06-29 Angiotech Pharmaceuticals, Inc., Vancouver Preparations and methods for treatment or prevention of diseases of the body passage routes
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US5945126A (en) * 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
DE69826994T2 (en) 1997-04-03 2005-12-08 Guilford Pharmaceuticals Inc. Biodegradable terephthalate polyester-polyphosphate polymers, compositions, articles and methods for their preparation and use
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US6162241A (en) * 1997-08-06 2000-12-19 Focal, Inc. Hemostatic tissue sealants
KR19990065921A (en) * 1998-01-19 1999-08-16 김충섭 Sustained-release preparation of the antibiotic
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6153212A (en) * 1998-10-02 2000-11-28 Guilford Pharmaceuticals Inc. Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
US6419709B1 (en) 1998-10-02 2002-07-16 Guilford Pharmaceuticals, Inc. Biodegradable terephthalate polyester-poly(Phosphite) compositions, articles, and methods of using the same
US6270802B1 (en) 1998-10-28 2001-08-07 Oakwood Laboratories L.L.C. Method and apparatus for formulating microspheres and microcapsules
GB2344287A (en) * 1998-12-03 2000-06-07 Ferring Bv Controlled release pharmaceutical formulation
CA2354514A1 (en) * 1998-12-15 2000-06-22 Wolff Walsrode Ag Biodegradable, thermoplastic shaped bodies exhibiting an improved stability with regard to hydrolysis and an improved resistance to stress cracking
US6350464B1 (en) 1999-01-11 2002-02-26 Guilford Pharmaceuticals, Inc. Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
US6537585B1 (en) 1999-03-26 2003-03-25 Guilford Pharmaceuticals, Inc. Methods and compositions for treating solid tumors
JP2004516262A (en) 2000-12-21 2004-06-03 ネクター セラピューティクス Induced phase transition method for the preparation of microparticles containing an hydrophilic active
JP2004535431A (en) 2001-06-22 2004-11-25 サザン バイオシステムズ, インコーポレイテッド Zero-order prolonged-release coaxial implant
CN100339057C (en) 2001-06-29 2007-09-26 麦德格夫特微技术公司 Biodegradable injectable implants and related method of manufacture and use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
EP1466596B8 (en) 2001-12-26 2017-01-11 Takeda Pharmaceutical Company Limited Microsphere and method for production thereof
JP2003192773A (en) * 2001-12-26 2003-07-09 Mitsui Chemicals Inc Bioabsorptive polyhydroxy carboxylic acid and its production method
US20040197301A1 (en) * 2003-02-18 2004-10-07 Zhong Zhao Hybrid polymers and methods of making the same
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US20080287400A1 (en) * 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) * 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080286359A1 (en) * 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20090275730A1 (en) * 2004-10-20 2009-11-05 Hiroyuki Oku Temperature responsive depsipeptide polymer
CN1923281B (en) * 2005-08-30 2010-05-05 孔庆忠 Anti-cancer slow release injection comprising plant alkaloid
CA2636716C (en) * 2006-01-13 2014-12-23 Surmodics, Inc. Microparticle containing matrices for drug delivery
KR20090017654A (en) * 2006-05-31 2009-02-18 박스터 헬쓰케어 에스.에이. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
TWI436793B (en) 2006-08-02 2014-05-11 Baxter Int Rapidly acting dry sealant and methods for use and manufacture
KR100845009B1 (en) * 2007-08-07 2008-07-08 한국생명공학연구원 Porous polymer particles immobilized charged molecules and method thereof
TWI461227B (en) 2007-10-30 2014-11-21 Baxter Int Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
JP5569398B2 (en) 2008-02-29 2014-08-13 フェッローサン メディカル ディバイス エー/エス Device for promoting hemostasis and / or wound healing
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
ES2532428T3 (en) * 2009-06-16 2015-03-26 Baxter International Inc hemostatic sponge
JPWO2011024944A1 (en) * 2009-08-31 2013-01-31 国立大学法人豊橋技術科学大学 Stereocomplex polyester and method for producing the same
CA2784432C (en) 2009-12-16 2019-01-15 Baxter Healthcare S.A. Hemostatic sponge
CN102939113B (en) 2010-04-07 2014-12-24 巴克斯特国际公司 Hemostatic sponge
WO2011151384A1 (en) 2010-06-01 2011-12-08 Baxter International Inc. Process for making dry and stable hemostatic compositions
BR112012030457A2 (en) 2010-06-01 2017-06-20 Baxter Healthcare Sa process for making a dry and stable hesostatic composition, method for delivering a hemostatic composition to a target site and providing a ready-to-use hemostatic composition, finished finished container, and kit for administering a hemostatic composition
JP5968308B2 (en) 2010-06-01 2016-08-10 バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated Process for making a dry and stable hemostatic composition
EP2598553B1 (en) 2010-07-26 2016-04-27 Université de Genève Compositions comprising polymers prepared from 2-hydroxyalkyl acids
WO2013053755A2 (en) 2011-10-11 2013-04-18 Baxter International Inc. Hemostatic compositions
CN103957949B (en) 2011-10-11 2017-07-18 巴克斯特国际公司 Hemostatic composition
TWI548417B (en) 2011-10-27 2016-09-11 Baxter Int Hemostatic composition
WO2013185776A1 (en) 2012-06-12 2013-12-19 Ferrosan Medical Devices A/S Dry haemostatic composition
JP6390873B2 (en) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー/エス Dry composition expanded under reduced pressure and syringe for holding the same
RU2678592C1 (en) 2013-12-11 2019-01-30 Ферросан Медикал Дивайсиз А/С Dry composition comprising extrusion enhancer
JP6148701B2 (en) * 2015-07-31 2017-06-14 ユニベルシテ ドゥ ジュネーブ Compositions comprising polymers prepared from 2-hydroxyalkyl acids
CN105111417A (en) * 2015-08-25 2015-12-02 杭州铭众生物科技有限公司 Preparing method for glycolic acid-hydracrylic acid random copolymer

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US329526A (en) 1885-11-03 Coal-mining machine
US368702A (en) 1887-08-23 bischoff
US467719A (en) 1892-01-26 Dust-guard for car-axle journals
NO139560C (en) 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate for preparing therapeutically active nonapeptidamid derivatives
JPS528375B2 (en) 1973-07-02 1977-03-09
FR2238700B1 (en) 1973-07-24 1977-10-14 Takeda Chemical Industries Ltd
AT347054B (en) 1973-09-29 1978-12-11 Takeda Chemical Industries Ltd Processes for production of new nonapeptidamid-derivatives
JPS5726506B2 (en) 1974-03-08 1982-06-04
DE2649146A1 (en) 1975-10-29 1977-05-12 Parke Davis & Co nonapeptides
JPS5944308B2 (en) 1976-03-23 1984-10-29 Takeda Chemical Industries Ltd
US4121577A (en) 1977-01-03 1978-10-24 Binder Timothy A Method and apparatus for aiding conditioning of an erect spinal column and advantageous muscle control
US4093574A (en) 1977-02-02 1978-06-06 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4087390A (en) 1977-02-02 1978-05-02 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4100117A (en) 1977-04-21 1978-07-11 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4253998A (en) 1979-03-09 1981-03-03 American Home Products Corporation Peptides related to somatostatin
US4277394A (en) 1979-04-23 1981-07-07 Takeda Chemical Industries, Ltd Tetrapeptidehydrazide derivatives
US4317815A (en) 1979-06-13 1982-03-02 Coy David Howard LH-RH Antagonists
US4622244A (en) * 1979-09-04 1986-11-11 The Washington University Process for preparation of microcapsules
US4253997A (en) 1979-12-17 1981-03-03 American Home Products Corporation Anti-ovulatory decapeptides
JPS6340199B2 (en) 1979-12-27 1988-08-10 Takeda Chemical Industries Ltd
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
DE3218151A1 (en) * 1982-05-14 1983-11-17 Akzo Gmbh Mikroporoese powder-polylactide and process for their preparation
JPH0157087B2 (en) * 1983-11-04 1989-12-04 Takeda Chemical Industries Ltd
JPH0678425B2 (en) 1984-07-06 1994-10-05 和光純薬工業株式会社 A new process for the preparation of polymer
CA1236641A (en) * 1984-07-06 1988-05-10 Motoaki Tanaka Copolymer of lactic acid and glycolic acid and method for producing same
AT61935T (en) * 1985-02-07 1991-04-15 Takeda Chemical Industries Ltd A process for the preparation of microcapsules.
JP2551756B2 (en) * 1985-05-07 1996-11-06 和光純薬工業株式会社 Polyoxyethylene carboxylic acid esters and their preparation
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
JP2526589B2 (en) * 1986-08-08 1996-08-21 武田薬品工業株式会社 Peptide-containing microcapsules and their preparation
JPH0725689B2 (en) * 1986-10-07 1995-03-22 中外製薬株式会社 Granulocyte colony - sustained-release preparation containing a stimulating factor
AU606383B2 (en) * 1987-03-06 1991-02-07 Research Triangle Institute Polymer blends for selective biodegradability
JPH0613602B2 (en) * 1987-07-14 1994-02-23 三井東圧化学株式会社 d ▲ l ▼ - lactic - production method of glycolic acid copolymer
US4897811A (en) 1988-01-19 1990-01-30 Nestor, Inc. N-dimensional coulomb neural network which provides for cumulative learning of internal representations
JP2827287B2 (en) * 1988-07-05 1998-11-25 武田薬品工業株式会社 Water-soluble drug-containing sustained release microcapsule
DE68927904D1 (en) 1988-09-01 1997-04-30 Takeda Chemical Industries Ltd Fumagillol derivatives
DE68915900T2 (en) 1988-09-01 1994-11-24 Takeda Chemical Industries Ltd Angiogenesis-inhibiting agent.
JPH0547525B2 (en) * 1989-02-14 1993-07-19 Japan Atomic Energy Res Inst
EP0415294A3 (en) 1989-08-31 1991-06-12 Takeda Chemical Industries, Ltd. Cyclohexanol derivatives, production and use thereof
CN2891061Y (en) 2006-03-15 2007-04-18 鸿富锦精密工业(深圳)有限公司 Integrated liquid crystal computer and its computer mainframe

Also Published As

Publication number Publication date
CN1116212A (en) 1996-02-07
RU2103005C1 (en) 1998-01-27
LV10055B (en) 1995-02-20
FI914865A (en) 1992-04-17
CN1060851A (en) 1992-05-06
LTIP442A (en) 1994-11-25
PT99236B (en) 1999-04-30
EP0481732B1 (en) 1995-03-01
NZ240214A (en) 1993-02-25
DK0481732T3 (en) 1995-05-22
FI914865D0 (en)
FI101454B (en) 1998-06-30
NO914032D0 (en) 1991-10-14
NO302481B1 (en) 1998-03-09
PT99236A (en) 1992-09-30
DE69107773T2 (en) 1995-06-29
FI914865A0 (en) 1991-10-15
CN1043189C (en) 1999-05-05
LV10055A (en) 1994-05-10
EP0481732A1 (en) 1992-04-22
AT119035T (en) 1995-03-15
JPH05112468A (en) 1993-05-07
IE66705B1 (en) 1996-01-24
CA2053468A1 (en) 1992-04-17
NO914032L (en) 1992-04-21
EE02958B1 (en) 1997-02-17
AU644019B2 (en) 1993-12-02
CN1057670C (en) 2000-10-25
JP3196035B2 (en) 2001-08-06
US5304377A (en) 1994-04-19
ES2069221T3 (en) 1995-05-01
CA2053468C (en) 2002-07-09
AU8586491A (en) 1992-04-30
DE69107773D1 (en) 1995-04-06
FI101454B1 (en) 1998-06-30
IE913624A1 (en) 1992-04-22
MX9101595A (en) 1992-06-05
LT3277B (en) 1995-05-25

Similar Documents

Publication Publication Date Title
GR3026099T3 (en) N-phenylphrazoles as insecticides and acaricides.
AP9100317A0 (en) Oligomers,their uses and formulations
AU7579991A (en) Pseudonucleosides and pseudonucleotides and their polymers
ZA9109797B (en) Bicyclo-5,6-dihydro-7h-pyrrolo-1,20-imidazol-7-ols and 7-ones
GR3024471T3 (en) Controlled release pharmaceutical preparation.
ZA9006201B (en) Diarylacetylenes,the preparation and use thereof
ZA9101362B (en) Polymers
IL97198D0 (en) Block copolymers and processes for the preparation thereof
EP0488258A3 (en) Propenamide derivatives, polymers, copolymers and use thereof
EP0580862A4 (en) Rapidly soluble solid preparation.
ZW1591A1 (en) Polymers
EP0450437A3 (en) Copolymers based on c1-c8-alkyl-acrylates and/or methacrylates, process for their preparation and their use
GB2241421B (en) Milk-based mousse, its preparation and use
AU9075591A (en) N-halochitosans, their preparation and uses
GR3026338T3 (en) High release solid preparation, preparation and use thereof
AU8586491A (en) Prolonged release preparation and polymers thereof
IL113364D0 (en) Stabilized halogen-containing polymers, their preparation and use
EP0501576A3 (en) Polymer preparation
ZA9101671B (en) Preparation of finely divided,water-soluble polymers
ZA9000966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
EP0442614A3 (en) Stabilized polymers and their preparation
GR3015160T3 (en) Peroxyacid-clathrates, their preparation and their uses.
IL110792D0 (en) Aldehydes and their preparation
IL99193D0 (en) Copolyimides,their preparation and their use
EP0494534A3 (en) Core-shell polymer